Taipei Medical University Institutional Repository:Item 987654321/4899
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 45073/58249 (77%)
Visitors : 2416067      Online Users : 160
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://libir.tmu.edu.tw/handle/987654321/4899


    Title: 探討人類卵巢濾泡液對鼠胚胎發育及著床能力之影響
    Study on the Promoting Factors for Mouse Embryo Development and Implantation in Human Follicular Fluid
    Authors: 黃基森
    Gi-Sern Huang
    Contributors: 醫學檢驗暨生物技術學研究所
    Keywords: 胚胎發育及著床調控
    粒線體膜電位
    脂質過氧化物
    懷孕率
    人類胎盤滋養層細胞
    著床
    濾泡液
    試管嬰兒
    囊胚孵化
    囊胚
    試管嬰兒
    In vitro fertilization
    infertile couples
    hatching rate
    blastocyst development rate
    ROS
    mitochondrial membrane potential
    follicular fluid
    Date: 2005
    Issue Date: 2009-09-10 17:20:07 (UTC+8)
    Abstract: 以試管嬰兒(in vitro fertilization; IVF)的技術來幫助不孕症夫婦孕育下一代是目前很重要的治療方式。但目前胚胎植入後之著床率只有15%~30%左右,還是低於一般正常夫婦,其主因被認為與胚胎的發育及著床有關,也使得對胚胎發育及著床調控的了解成為刻不容緩之課題。當以試管嬰兒技術來培養胚胎時,是否由於缺少濾泡液之參與,才造成囊胚之發育率及著床懷孕率一直無法提高,此乃是目前亟待釐清的問題。各種研究顯示濾泡液內之各種成分可促使卵成熟、促使濾泡細胞之增殖(proliferation)與分化(differentiation)、吸引精子,促進卵與精子的受精能力,甚或提高懷孕率。因此本論文的主要主題是探討並尋找人類濾泡液中是否有可以促進胚胎發育及著床因子之存在,並對於其作用機轉加以研究。本研究將濾泡液作不同方式加熱處理後,分別與2細胞(two cells)期鼠胚(ICR mouse embryos)進行培養,發現皆有促進胚胎發育之潛能。其中以100℃、30分鐘處理之濾泡液組(heated human follicular fluid, hFF100 ),其增加胚胎發育至囊胚(blastocyst)的比例為對照組的1.18倍,具有顯著性差異(p<0.05) 。而囊胚孵化(hatching)則為對照組的1.38倍,具有顯著性差異(p<0.05) 。進一步以Matrigel進行著床(implantation)評估,亦有 增加著床之能力,為對照組之1.03倍,但經統計運算後則無明顯差異(p>0.05)。將hFF100以單向電泳SDS-PAGE分析則發現有3個主要蛋白質,其分子量約為53kDa、40kDa及21kDa。當以JC-1螢光染色探討各胚胎期之粒線體功能時,發現經10%hFF100培養鼠胚後,比對照組有表現較高的粒線體膜電位(mitochondrial membrane potential, △Ψ),顯現出其粒線體功能較活躍,而且對外加100M之H2O2處理也較有保護效果。我們在脂質過氧化物(lipid peroxide)螢光染色的實驗中也發現,在10%hFF100培養下之鼠胚比對照組產生的量少,因此證實hFF100濾泡液具有保護胚胎降低ROS傷害的機制。此外,我們更進一步利用人類胎盤滋養層細胞(trophoblast cells)的培養來確認hFF100對胎盤細胞的影響。當胎盤滋養層細胞與10% hFF100培養48小時後,其ATP產量較對照組增加0.13倍,而且於著床時入侵(invasion)所需因子matrix metalloproteinase-2 ( MMP-2 )、matrix metalloproteinase-9 ( MMP-9 )及tissue-inhibitors metalloproteinase-1 (TIMP-1)之mRNA表現亦呈增加之現象,在著床黏附因子integrin -5及血管新生因子vascular endothelial growth factor (VEGF)之mRNA也有明顯增加,因此可進一步證實hFF100應可促進胚胎表現與著床相關之因子進而促進其著床。綜合以上實驗結果,我們認為經過100℃、30分鐘處理的人類濾泡液,確實可增加著床前胚胎之發育,並可保護胚胎減少受ROS之傷害,以及加強粒線體功能,使得胚胎能順利發育到囊胚,進而孵化以及著床,因此應可進一步利用在人類胚胎之培養上,增加胚胎發育至囊胚之數目,進而提高著床率及懷孕率,造福罹患不孕症之夫婦。
    In vitro fertilization (IVF) techniques is the very important treatment that help infertile couples breeding next generation. The implantation rate of embryo in human IVF and embryo transfer treatment has been reported to approximately around 15 to 30%, which is still lower than in normal fertile couples. The main reason considered about the low pregnancy rate and blastocyst development rate in IVF treatment course could possibly be due to pre-implantational embryo culture without follicular fluid in vitro. Follicular fluid is known to promote oocyte maturation, proliferation and differentiation of follicular cells and affect sperm capacitation, acrosome reaction, sperm quality, sperm-oocyte fusion, and can even increase the pregnancy rate. In this study, we searched for the factors that could promote embryo development and implantation in human follicular fluid and elucidate the regulation mechansim. After processing the human follicular fluid by heating at different temperature at 56℃ (hFF56) and 100℃ (hFF100) for 30 min, we examined the blastocyst development rate, hatching rate, and implantation rate by 10% (v/v) of both types of follicular fluids supplementation with two-cell embryo of ICR mouse. 1.18 fold increased of blastocyst development rate (p<0.05) and 1.38 fold increased of hatching rate (p<0.05) were found in the hFF100 treated embryos. The implantation rate was found to be 1.03 fold increased compared with control group by using Matrigel invasion assay, but no significantly difference between two groups (p>0.05). There are three different bands in the hFF100 fraction after SDS-PAGE electrophoresis, approximate molecular weights of 53kDa, 40kDa and 21kDa, respectively. Higher mitochondrial membrane potential (△Ψ) was detected in the hFF100-treated embryos by JC-1 staining. We also found the lower lipid peroxides contents of hFF100 pre-treated embryos followed 100 M hydrogen peroxide treatment. The more active mitochondria and protection from ROS damages were addressed in the hFF100 treated embryos. Furthermore, we also used the trophoblast cell as the cell culture model to identify the effects of the hFF100 on embryo implantation. After 48 hours cultured with the 10 %(v/v) hFF100, the ATP production increased 0.13 fold compared with control. Increased mRNA expressions of the factors involved in embryo invasion and implantation were detected including MMP-2, MMP-9, TIMP-1, integrin-5, and VEGF. According to our findings, we suggested that the hFF100 treatment could improve embryo development potential and implantation capability.In conclusion, heated human follicular fluid to 100℃ for 30 min could definitely increase the developmental potential of mouse pre-implatational embryos and increase the protective effect against ROS damage as well as enhance mitochondria function. These effects of hFF100 could aid the pre-implantation embryo more efficiency to develop to blastocyst, hatching and even implantation. These finding could support that follicular fluid supplementation in the human IVF culture to improve the blastocyst formation and finally enhance the implantation and pregnancy rate of infertile couples to bear their own baby.
    Data Type: thesis
    Appears in Collections:[ ] Dissertations/Theses

    Files in This Item:

    File Description SizeFormat
    摘要.doc33KbMicrosoft Word87View/Open
    摘要.pdf81KbAdobe PDF117View/Open
    摘要.ppt121KbMicrosoft Powerpoint201View/Open
    摘要.ps576KbPostscript51View/Open


    All items in TMUIR are protected by copyright, with all rights reserved.


    著作權聲明 Copyright Notice
    • 本平台之數位內容為臺北醫學大學所收錄之機構典藏,包含體系內各式學術著作及學術產出。秉持開放取用的精神,提供使用者進行資料檢索、下載與取用,惟仍請適度、合理地於合法範圍內使用本平台之內容,以尊重著作權人之權益。商業上之利用,請先取得著作權人之授權。

      The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use. Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner.

    • 瀏覽或使用本平台,視同使用者已完全接受並瞭解聲明中所有規範、中華民國相關法規、一切國際網路規定及使用慣例,並不得為任何不法目的使用TMUIR。

      By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in the statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions. Furthermore, users must not use TMUIR for any illegal purposes.

    • 本平台盡力防止侵害著作權人之權益。若發現本平台之數位內容有侵害著作權人權益情事者,煩請權利人通知本平台維護人員([email protected]),將立即採取移除該數位著作等補救措施。

      TMUIR is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff([email protected]). We will remove the work from the repository.

    Back to Top
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback